<DOC>
	<DOCNO>NCT01305109</DOCNO>
	<brief_summary>The trial phase III randomize , double-blind , placebo-controlled trial primary objective evaluating efficacy three dos ORV 116E , 10^5.0 FFU , severe rotavirus gastroenteritis , comparison placebo India .</brief_summary>
	<brief_title>A Phase III Clinical Trial Evaluate Protective Efficacy Three Doses Oral Rotavirus Vaccine ( ORV ) 116E</brief_title>
	<detailed_description>The trial phase III randomize , double-blind , placebo-controlled trial primary objective evaluating efficacy three dos ORV 116E , 10^5.0 FFU , severe rotavirus gastroenteritis , comparison placebo India . The clinical trial global trial . Three administration ORV 116E co-administered childhood vaccine ( include vaccine diphtheria , pertussis , tetanus , Haemophilus influenzae B Hepatitis B OPV ) 6 7 week , great equal 10 week great equal 14 week age . 6800 subject enrol three site - Delhi , Pune ( Maharashtra ) Vellore ( Tamil Nadu ) follow till age 2 year ( 24 month + 14 day ) . Multiple trial site include ensure great demographic distribution obtain evidence cross immunity quicker recruitment necessary number subject . The subject include site would representative population India . The protocol review institutional review board Society Applied Studies ( New Delhi ) , KEM Hospital Research Centre ( Pune ) , Christian Medical College ( Vellore ) . Ethics clearance also obtain Department Biotechnology , Government India Western Institutional Review Board .</detailed_description>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least one parent ( ) legally acceptable representative 's consent participation able understand study procedures Subjects age 6 7 week recruitment No plan move next 24 month Administration rotavirus vaccine past Presence illness require hospital referral ( temporary exclusion ) Known case immunodeficiency disease , know HIV positive Known case chronic gastroenteritis disease Any condition judgment investigator warrant exclusion ( e.g . exclusion criterion seem `` ill '' , investigator suspect neglect ) Diarrhea day enrollment ( temporary exclusion )</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>7 Weeks</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>